CNS & Neurological Disorders - Drug Targets
Title:Editorial (Thematic Issue: Translational Neuroscience: Narrowing Distances for Future Discoveries)
Volume: 14 Issue: 8
Author(s): Jose Alexandre De Souza Crippa, Francisco Silveira Guimaraes and Samia Joca
Affiliation:
Export Options
About this article
Cite this article as:
De Souza Crippa Alexandre Jose, Guimaraes Silveira Francisco and Joca Samia, Editorial (Thematic Issue: Translational Neuroscience: Narrowing Distances for Future Discoveries), CNS & Neurological Disorders - Drug Targets 2015; 14 (8) . https://dx.doi.org/10.2174/1871527314999150909115443
DOI https://dx.doi.org/10.2174/1871527314999150909115443 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Relationship between Endothelial Nitric Oxide Synthetase Gene Variants and Substance Use Disorder
Endocrine, Metabolic & Immune Disorders - Drug Targets When Ubiquitin Meets NF-κB: A Trove for Anti-cancer Drug Development
Current Pharmaceutical Design UBQ-8i Polymorphism is not An Independent Risk Factor for Mild Cognitive Impairment and Alzheimer’s Disease in APOE-4 Carriers
Current Alzheimer Research Monoamine Oxidases: Certainties and Uncertainties
Current Medicinal Chemistry Editorial (Hot Topic: G Protein-Coupled Receptor Biased Agonism: Development Towards Future Selective Therapeutics)
Mini-Reviews in Medicinal Chemistry Lamotrigine as an Effective Treatment for Behavioral Disorders
Letters in Drug Design & Discovery AMPA Receptors in the Therapeutic Management of Depression
CNS & Neurological Disorders - Drug Targets Stereoselectivity in Drug Metabolism: Molecular Mechanisms and Analytical Methods
Current Drug Metabolism Exosome-based strategies for Diagnosis and Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Induced Pluripotent Stem Cells, New Tools for Drug Discovery and New Hope for Stem Cell Therapies
Current Molecular Pharmacology Protein Geranylgeranyltransferase Type 1 as a Target in Cancer
Current Cancer Drug Targets Gut Permeability and Microbiota in Parkinson’s Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
Current Pharmaceutical Design Subcutaneous Immunoglobulins: A Promising Alternative for Immunomodulation?
Current Pharmaceutical Design Therapeutic Potential of Vitamin D for Multiple Sclerosis
Current Medicinal Chemistry Electroconvulsive Therapy in Child and Adolescent Psychiatry
Current Psychiatry Reviews Statistical Identification of Gene-gene Interactions Triggered By Nonlinear Environmental Modulation
Current Genomics Curcumin-glucoside, A Novel Synthetic Derivative of Curcumin, Inhibits α-Synuclein Oligomer Formation: Relevance to Parkinson's Disease
Current Pharmaceutical Design Brain-derived Neurotrophic Factor Genetic Variants are Associated with Major Depression Susceptibility and Serotonin Reuptake Inhibitor Antidepressant Treatment Response in Taiwanese
Current Pharmacogenomics and Personalized Medicine Progress of Biological Agents on Psoriatic Arthritis
Current Pharmaceutical Biotechnology LINE-1 Methylation is Associated with an Increased Risk of Ischemic Stroke in Men
Current Neurovascular Research